ASAM is proud to partner with its 39 independent State Chapters to advance access to high-quality, evidence-based addiction treatment.

State Advocacy

State Capitol

On a diverse set of issues ranging from mental health and addiction parity to pharmacy regulation, American Society of Addiction Medicine (ASAM) State Chapters are instrumental in shaping addiction policy conversations in state capitols across the country.  ASAM National staff can track addiction-related state legislation and regulations; help keep State Chapters informed of state policy developments, and provide them with consultation and technical assistance on state-level issues important to them. In addition, ASAM National staff closely works with many other national organizations on mental health and addiction issues and can connect ASAM State Chapters with those national organizations and their state branches.

UTSAM Opposes Legislation Establishing New Medical Cannabis Provider Type

February 12, 2021

 

On February 12, the Utah Society of Addiction Medicine (UTSAM) submitted a letter in opposition to SB170, which would establish a new provider type under Utah’s medical cannabis law. Currently only qualified medical providers may recommend medical cannabis to a patient. Qualified medical providers are clinicians who must satisfy an array of conditions including licensure under the state's controlled substances law, and receiving continuing medical education (CME) on recommending cannabis. Furthermore, qualified medical providers may not to own, or be employed by, a cannabis production establishment, a medical cannabis pharmacy, or a medical cannabis courier.

 

SB170 would create a new provider type, called “limited medical provider.” This provider type would also be a clinician licensed under the state's controlled substances law. However, this provider type would not be required to complete the CME on recommending cannabis, and furthermore, would be allowed to own, or be employed by, a cannabis production establishment, a medical cannabis pharmacy, or a medical cannabis courier. These limited medical providers would only be able to recommend cannabis to up to 15 patients. UTSAM’s letter focused on the importance of ensuring that clinicians recommending medical cannabis are sufficiently educated on the drug before they recommend it. Furthermore, it noted that cannabis is associated with a myriad of health risks, and has not been approved by the Food and Drug Administration for any medical indication. 

 

Read the letter here.

 

Read the bill here

 

Legislative Tracking

ASAM tracks legislation relating to its chapters' legislative priorities in all 50 states. 

Chapter Leadership

ASAM's state chapters are led by experts in the field of addiction medicine. Each chapter elects its own leaders. 

East - Regions I, III, IV, V, X

West - Regions II, VI, VII, VIII

State Advocacy Resources

Find tools designed to help support your advocacy efforts with state legislators and regulators here. 

Subscribe to the ASAM Advocate

Your source for timely, useful news briefings of top stories in addiction policy.